Valuation: TaiRx, Inc.

Market Cap 1.63B 51.02M 45.56M 42.5M 38.61M 72.65M 4.94B 73.36M 510M 200M 2.51B 192M 187M 8.08B P/E 2024
-20.5x
P/E 2025 -11x
Enterprise Value 1.3B 40.69M 36.33M 33.89M 30.79M 57.94M 3.94B 58.5M 407M 159M 2B 153M 149M 6.44B EV / Sales 2024
286x
EV / Sales 2025 75.1x
Free-Float
100%
Yield 2024 *
-
Yield 2025 -
1 day-0.34%
1 week-8.49%
Current month-8.49%
1 month+15.48%
3 months+8.99%
6 months-3.64%
Current year-33.56%
1 week 14
Extreme 14
15.8
1 month 12.3
Extreme 12.3
16.35
Current year 11.95
Extreme 11.95
23.45
1 year 11.95
Extreme 11.95
26.2
3 years 11.95
Extreme 11.95
44
5 years 11.95
Extreme 11.95
89.5
10 years 11.95
Extreme 11.95
89.5
Manager TitleAgeSince
Investor Relations Contact - -
Chief Executive Officer - 2011-08-21
Director of Finance/CFO - 2015-10-04
Director TitleAgeSince
Chairman - 2011-08-21
Director/Board Member - 2013-12-17
Director/Board Member - 2011-08-21
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%-8.49%-44.25%-49.21% 51.37M
-3.19%-3.19%+44.60%+87.98% 74.68B
-15.86%-16.16%+2.68%+50.90% 58.7B
-2.39%-2.05%+4.29%+31.33% 48.36B
-6.35%-8.63%+293.39%+651.28% 43.05B
+0.30%-0.71%+29.05%+30.33% 42.48B
-3.82%-2.41%-0.27%+101.36% 41.39B
-2.13%+1.07%+7.51%+50.31% 31.29B
-3.35%-4.95%-13.38%-17.22% 23.93B
-1.24%-7.47%-37.90%+311.13% 22.22B
Average -3.84%-3.01%+28.57%+124.82% 38.62B
Weighted average by Cap. -4.86%-1.88%+43.04%+136.39%

Financials

2024 2025
Net sales 8.22M 257K 230K 214K 195K 366K 24.9M 370K 2.57M 1.01M 12.65M 965K 944K 40.7M 27.88M 872K 778K 726K 660K 1.24M 84.43M 1.25M 8.72M 3.41M 42.9M 3.27M 3.2M 138M
Net income -139M -4.34M -3.88M -3.62M -3.29M -6.18M -421M -6.24M -43.43M -16.99M -214M -16.3M -15.95M -687M -221M -6.92M -6.18M -5.76M -5.23M -9.85M -670M -9.94M -69.17M -27.05M -340M -25.97M -25.4M -1.09B
Net Debt -505M -15.79M -14.1M -13.15M -11.95M -22.48M -1.53B -22.7M -158M -61.77M -777M -59.28M -58M -2.5B -330M -10.33M -9.23M -8.61M -7.82M -14.71M -1B -14.86M -103M -40.42M -509M -38.8M -37.95M -1.64B
Projected Income Statement - Annual - TaiRx, Inc.
Logo TaiRx, Inc.
TaiRx Inc is a Taiwan-based company mainly engaged in the development and research of new drugs. The Company primarily focus on the research and development of cancer treatment drugs and sepsis adjuvant therapy drugs. The Company's main products include CVM-1118, Rexis, Zelnite, TRX-NOC, TRX-920, TRX-711, TRX-105 and others. CVM-1118 and Rexis are in clinical trials, and Zelnite drugs are sold to domestic medical institutions at all levels through distributors.
Employees
-
Date Price Change Volume
26-10-08 NT$14.55 -0.34% 72,075
26-10-07 NT$14.60 -2.99% 153,246
26-10-06 NT$15.05 -2.59% 88,956
26-10-05 NT$15.45 -0.64% 53,599
26-10-02 NT$15.55 -0.96% 114,738
  1. Stock Market
  2. Stocks
  3. 6580 Stock